Startups
Edit
NEXT Oncology San Antonio
http://www.nextoncology.com/Last activity: 14.10.2025
Probably Closed
NEXT Oncology, founded by Anthony W. Tolcher, M.D., FRCPC, is a Phase 1 center dedicated to providing options for advanced cancer patients and advancing cancer research. Dr. Tolcher’s passion for research and the community lays the foundation for an international brand committed to finding the next breakthrough. Dr. Anthony Tolcher is a medical oncologist and co-founder of NEXT. He is dedicated to the development of new anticancer agents for patients whose current cancer therapy is no longer working to benefit them and are looking for their next option that includes clinical trials of new agents and therapies. Dr. Tolcher is proud that at NEXT Oncology the team scours the world to bring the best new agents back to our patients and centers. This is not a job for Dr. Tolcher, it is his passion.
Overview
Location
United States, Texas, San Antonio
Employees
11-50
Founded date
2018
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 13, 2025 | Everest Medicines Announces NMPA Approval of IND Application for Tumor-Associated Antigen Cancer Vaccine EVM14 | EVM14 becomes Everest Medicines' internally developed therapeutic mRNA cancer vaccine to receive IND approvals from both China's National Medical Products Administration (NMPA) and the U.S. Food and Drug Administration (FDA). EVM14, an off-... |
| Oct 16, 2024 | The Value of edX Certificates: Are They Worth Your Investment? | In the digital age, education has transformed. Online platforms like edX have become the new classrooms. They offer courses from prestigious institutions like Harvard and MIT. But are edX certificates worth the money? Let’s dive into the de... |
| Oct 15, 2024 | Circle Pharma Announces First Patients Dosed in Phase 1 Clinical Trial of First-in-Class Oral Cyclin A/B RxL Inhibitor CID-078 for Advanced Solid Tumors | SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–October 15, 2024– Circle Pharma, Inc., a clinical-stage biopharmaceutical company dedicated to discovering and developing a new generation of macrocycle therapies, announced today that the first p... |
| Apr 18, 2023 | MatTek Life Sciences and NEXT Oncology Announce Licensing Agreement to Develop Lab-Grown Tumors | “Using the panel of cancer types, we will develop a drug screening protocol that can determine effective drugs for specific cancer types and be applied for personalized medicine,” said Dr. Anthony Tolcher, CEO and founder of NEXT Oncology. ... |
Reviews 0
FAQ about NEXT Oncology San Antonio
When was NEXT Oncology San Antonio founded?
NEXT Oncology San Antonio was founded in 2018.
What has the press written about NEXT Oncology San Antonio?
Parsers VC has collected 5 articles mentioning NEXT Oncology San Antonio, among them “Everest Medicines Announces NMPA Approval of IND Application for Tumor-Associated Antigen Cancer Vaccine EVM14” (Oct 13, 2025) and “The Value of edX Certificates: Are They Worth Your Investment?” (Oct 16, 2024).
Is NEXT Oncology San Antonio still active?
NEXT Oncology San Antonio is probably closed: its latest activity on Parsers VC dates from Oct 14, 2025.